Redsense Medical AB enters 2020 with new orders, total order book value now MSEK 2

Report this content

Following the turn of the year, Redsense Medical has during the first days of January received an influx of new orders to a combined value of more than MSEK 1.5; these new orders bring the Company’s current total order book value up to approximately MSEK 2.

In the last quarters of 2019, the Company’s order backlog increased significantly as market demand kept rising. In response to this development, Redsense has previously announced a set of measures to strengthen production capacity and meet the growing demand.

”We are happy to see that we are continuing to receive orders at an impressive rate; this is an indication that Redsense’s solutions remain in high demand, and points to growing sales ahead. We are entering 2020 with optimism and confidence as we are convinced that we will have the most exciting and strongest year yet” says Patrik Byhmer, CEO of Redsense Medical AB.

For more information, please contact:

Patrik Byhmer, CEO Redsense Medical AB (publ)

Phone: +46 35 10 60 30


Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovationused for monitoring and alarm in the case of blood leakage in connection with hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.


Documents & Links